Spyre Therapeutics Rings the Opening Bell

About This Event

Spyre Therapeutics (Nasdaq: SYRE), a biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations and precision medicine approaches for the treatment of inflammatory bowel disease (IBD), visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Cameron Turtle, Chief Executive Officer, rings the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore